Trump demands U.S. drug prices match lowest international rates for some or face executive action. This article originally ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

President Trump has taken a firm stance on reducing American drug prices, sending letters to 17 major pharmaceutical ...

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

When President Donald Trump hits "post" on Truth Social, Wall Street braces for impact. What Happened: Various stock prices — ...

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

Pfizer CEO Albert Bourla said his company is in “very active discussions” over Trump’s request concerning most-favoured-nation pricing, according to news website FiercePharma. Bourla said he had ...

Pharmaceuticals account for the bulk of Irish exports to the US and any change, or even uncertainty, on tariffs poses major ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.

The Health and Human Services secretary cancelled nearly $500 million in contracts related to the development of future ...

Kennedy Jr. pulled the plug Tuesday on half a billion dollars of vaccine research, POLITICO’s David Lim reports. The longtime ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...